Biotech startup building research facility in Vancouver, B.C. for radiotherapies lands $75M – GeekWire


Alpha-9 Theranostics, a Vancouver, B.C. and Boston-based biotech company developing radiotherapies, raised $75 million. The company was founded by researchers from the University of British Columbia and BC Cancer, and is led by David Hirsch, a venture partner at Longitude Capital, which led a previous $11 million Series A funding round. The company is building a research facility in Vancouver to advance development of its agents that selectively target radioisotopes to cancer cells. Nextech Invest led the Series B round, with participation from Longitude and other investors.


Source link

Related posts

While NASA gets set for first Artemis mission, Aerojet works ahead

Laura Peterson

Getty Images set to go public Monday after completing SPAC merger – GeekWire

Laura Peterson

Startup building software that helps airlines upsell customers raises $25M – GeekWire

Laura Peterson